Skip to content

psychedelics

2 Psychedelic Stocks That Will Skyrocket, According To Wall Street

Psychedelics—psychotropic drugs that trigger altered states of consciousness—are gaining widespread attention. Over the past two decades, research in the area has increased, with a magic mushroom ingredient—psilocybin—showing promise for treating a range of mental health disorders and addictions. In addition, a CB Insights market research report has shown that psychedelic medicine funding was set to cross $700 million in 2021, which is… 

CLICK HERE »2 Psychedelic Stocks That Will Skyrocket, According To Wall Street

7 Psychedelic Stocks To Watch

Here are seven top psychedelic drug stocks that investors should watch. In November 2020, Oregon made history by becoming the first U.S. state to legalize psilocybin, the active ingredient in so-called magic mushrooms. Much like cannabis, psychedelics are becoming more mainstream, and investors are sizing up what could be a major long-term growth opportunity, especially as companies develop therapeutic uses… 

CLICK HERE »7 Psychedelic Stocks To Watch